Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №1 (2025) > Analysis of immunohistochemical study results for lung cancer detected in the Khorezm region

Analysis of immunohistochemical study results for lung cancer detected in the Khorezm region

Akbar P. Ortikov

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Abstract
This article evaluates the histological characteristics of patients living in the Khorezm region, diagnosed with lung cancer, who were treated at the Khorezm branch of the Republican Specialized Scientific and Practical Center for Oncology and Radiology and were under the supervision of the dispensary during 2020–2023, based on the data obtained from our retrospective study of the results of biopsy reports. Resections were taken from tissues obtained by surgery and biopsy. For immunohistochemical examination, cell expression was studied using Ki-67, bcl-2, TTF, p53 and Cytokeratin 5/6 monoclonal antibodies using Bond Leica Australia (Australia) immunohistoprocessor and the results of the analysis obtained during the microscopic study of histological and immunohistochemical changes in the histological forms of lung cancer are described.
Keywords: lung cancer, microscopic changes, histological forms of lung cancer. 

About the Author

Akbar P. Ortikov
Akbar P. Ortikov 

Urgench Branch of the Tashkent Medical Academy, Urgench, Khorezm Region, Uzbekistan 
ortiqovakbar1977@gmail.com

References

1. Епишкина А.А. и др. Морфологическая и иммуногистохимическая валидация персонализированной биологической in vivo платформы немелкоклеточного рака легкого человека. Журнал анатомии и гистопатологии. 2023;11(4):53-7.
Epishkina A.A. et al. Morphological and immunohistochemical validation of a personalized biological in vivo platform for human non-small cell lung cancer. Journal of Anatomy and Histopathology. 2023;11(4):53-7 (in Russian).
2. Комарова Е.Ф. и др. Иммуногистохимическая оценка возможных механизмов противоопухолевого действия 2-(6, 8-диметил-5-нитро-4-хлорхинолин-2-ил)-5, 6, 7-трихлор-1, 3-трополона на PDX-моделях рака легкого. Южно-российский онкологический журнал. 2023;4(1):6-13.
Komarova E.F. and others et al. Immunohistochemical evaluation of possible mechanisms of antitumor action of 2-(6, 8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5, 6, 7-trichloro-1, 3-tropolone on PDX models of lung cancer. South Russian Journal of Cancer. 2023;4(1):6-13 (in Russian).
3. Ежов Д.А., Сычева Д. Р. Иммуногистохимические особенности паренхимы и стромы рака легкого. Forcipe. 2020;3(S):645-6.
Yezhov D.A., Sycheva D. R. Immunohistochemical features of lung cancer parenchyma and stroma. Forcipe. 2020;3(S):645-6 (in Russian).
4. Костицын К.А. и др. Спектральные, морфологические и иммуногистохимические характеристики центрального рака легкого и предопухолевых изменений. Вопросы онкологии. 2022;68(S3):110-2.
Kostitsyn K.A. et al. Spectral, morphological, and immunohistochemical characteristics of central lung cancer and precancerous changes. Issues of oncology. 2022;68(S3):110-2 (in Russian).
5. Минина В.И. и др. Экспрессия гена ERCC2 в клетках периферической крови у больных раком легкого. В кн.: Advances in Science and Technology. XXX Международная научно-практическая конференция. М.: Актуальность РФ, 2020. С. 55.
Minina V.I. et al. ERCC2 gene expression in peripheral blood cells of lung cancer patients. In: Advances in Science and Technology. XXX International Scientific and Practical Conference. Moscow: Actualnots.RF, 2020. P. 55 (in Russian).
6. Савостикова М.В., Фурминская Е.Ю. Цитологическая и иммуноцитохимическая диагностика опухолей легких. Вестник ФГБУН «РОНЦ им. Н.Н.Блохина». 2015;26(3):29-38.
Savostikova M.V., Furmanskaya E.Y. Cytological and immunocytochemical diagnostics of lung tumors. Bulletin of the N.N.Blokhin Russian Scientific Research Center. 2015;26(3):29-38 (in Russian).
7. Губенко М.С. и др. Метилирование ДНК в регуляции экспрессии генов системы апоптоза при немелкоклеточном раке легкого. Патологическая физиология и экспериментальная терапия. 2022;66(4):5-12.
Gubenko M.S. et al. DNA methylation in the regulation of gene expression of the apoptosis system in non-small cell lung cancer. Pathological physiology and experimental therapy. 2022;66(4):5-12 (in Russian).
8. Гуревич Л.Е. и др. Значение иммуногистохимии для таргетной терапии и прогнозирования в онкологии. Альманах клинической медицины. 2012;(27):27-34.
Gurevich L.E. et al. The importance of immunohistochemistry for targeted therapy and prognosis in oncology. The Almanac of Clinical Medicine. 2012;(27):27-34 (in Russian).

For citation:Ortikov A.P. Analysis of immunohistochemical study results for lung cancer detected in the Khorezm region. Clinical review for general practice. 2025; 6 (1): 132–137 (In Russ.). DOI: 10.47407/kr2024.6.1.00562


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru